65,437 trials
Osteoarthritis Knee Pain
Primary: Change From Baseline in the Weekly Mean of the 24-Hour Average Pain Score at 8 Weeks — -1.55; -2.46 units on a scale — p=<0.001
COPD
Primary: Bronchodilator Response:Peak FEV1(L)(Forced Expiratory Volume in One Second)- — 1.74; 1.82 liters — p=0.027
Cystic Fibrosis
Primary: Number of Subjects With Adverse Events (Combined Part 1 and Part 2) — 7; 26; 3; 13 participants
Pain · Cancer
Primary: Percentage of Participants With Adverse Events. — 88.5 percentage of participants
Anxiety
Primary: Change in VAS Anxiety Score Relative to Baseline After Premedication — 0.35; 0.70; 0.65; 0.25 Centimeter
Obstructive Sleep Apnea
Primary: Quality of Polysomnographic Recordings — 10 percentage of recording failure
Bone Health in Perimenopausal Women
Primary: Changes in DPD(Deoxypyridinoline) — 7.1; 6.4; 6.2; 5.6 nanoMolar DPD per milliMolar creatine
Chemotherapy-induced Nausea and Vomiting
Primary: Investigator Global Assessment of Participants' Response to Therapy With EMEND (Aprepitant) for the Prevention of Acute and Delayed Nausea Following Chemotherapy — 438…
Lymphoma
Primary: Number of Participants With Adverse Events (e.g. Toxicity) — 28 Participants
Schizophrenia · Bipolar I Disorder
Primary: Incidence and Nature of Adverse Events (AEs) — 321 Participants
Sleep Apnea
Primary: Change in the Apnea/Hypopnea Index (AHI) Between Baseline and Week 28/Early Term. — -16.6; -31.46 events/hour — p=0.0084
Respiratory Syncytial Virus Bronchiolitis
Primary: Percentage of Participants With Asthma at 6 Years of Age: Overall and by Prognostic Factor — 6.1; 11.2; 3.1; 9.6 percentage of participants
Androgenetic Alopecia
Primary: Change From Baseline (BL) in Target Area Hair Count (HC) Within a 2.54 Centimeter (cm) (1 Inch) Diameter Circle at the Vertex at Week 24, as Assessed by…
Rubeosis Iridis · Proliferative Diabetic Retinopathy
Primary: Adverse Event (AE) — 0 participants
Hyperlipidemia
Primary: Changes in LDL-cholesterol(Low Density Lipoprotein - Cholesterol) — 150.6; 150.1; 155.8; 156.3 mg/dl